Trial TEAM

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

TEAM

Full title

Targeting Epigenetic therapy resistance in AML with Bortezomib: A multi-centre matched threshold crossing phase II approach

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Classification	Code	Description
-		Bloodcancer (leukemia, lymphoma)

Phase

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Zielgerichtet - Therapieart: palliativ

	Function	Prename	Surname	Organization
	Responsible contact	Katharina	Götze	3. Med 3. Med Ismaninger Str. 22 81675 München Germany